Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desmopressin + oxybutynin vs fluvoxamine for nocturnal enuresis in children
IRCT20171112037417N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Apr 2018
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3 trial of desmopressin, oxybutynin and fluvoxamine in nocturnal enuresis (NE) (2 arms), sponsored by Mashhad University of Medical Sciences. Started Apr 2018; status: completed.
02
Drugs
desmopressinoxybutyninfluvoxamine
03
Conditions
nocturnal enuresis (NE)
Beyond the preview
Go deeper on IRCT20171112037417N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20171112037417N1.